2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Robbie Majzner: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| B7-H3.CD28Z.CART in CNS Neoplasms B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide - Central Nervous System Neoplasms, Brain Tumor | Phase 1 | Recruiting | Robbie Majzner | 70 | 2026-09-01 | 2026-09-03 |
| B7-H3.CD28Z.CART in Solid Tumors B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide - Pediatric Solid Tumor, Neuroblastoma | Phase 1 | Recruiting | Robbie Majzner | 40 | 2026-08-24 | 2026-09-03 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Medulloblastoma (1) · Meningeal Neoplasms (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Pinealoma (1) · Rhabdoid Tumor (1)
Cyclophosphamide (2) · fludarabine (2) · fludarabine phosphate (1)
United States (2)
Natalie Collins, MD (1) · Susan Chi (1)